{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:12:11Z","timestamp":1746191531501,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["959\/11"],"award-info":[{"award-number":["959\/11"]}],"id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0845-y","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T16:27:32Z","timestamp":1490632052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS)"],"prefix":"10.1186","volume":"17","author":[{"given":"D.","family":"Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Canham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cotterill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"issue":"6 Pt 1","key":"845_CR1","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.juro.2006.08.017","volume":"176","author":"JT Hakkinen","year":"2006","unstructured":"Hakkinen JT, Hakama M, Shiri R, Auvinen A, Tammela TL, Koskimaki J. Incidence of nocturia in 50 to 80-year-old Finnish men. J Urol. 2006;176(6 Pt 1):2541\u20135. discussion 5.","journal-title":"J Urol"},{"key":"845_CR2","unstructured":"Kaminska M, Kimoff RJ, Benedetti A, Robinson A, Bar-Or A, Lapierre Y, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. 2011; http:\/\/msj.sagepub.com\/content\/early\/2011\/12\/06\/1352458511432328(E-pub )."},{"issue":"5","key":"845_CR3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2010.09763.x","volume":"107","author":"DM Gulur","year":"2011","unstructured":"Gulur DM, Mevcha AM, Drake MJ. Nocturia as a manifestation of systemic disease. BJU Int. 2011;107(5):702\u201313.","journal-title":"BJU Int"},{"issue":"6","key":"845_CR4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.urology.2015.02.043","volume":"85","author":"SD Marshall","year":"2015","unstructured":"Marshall SD, Raskolnikov D, Blanker MH, Hashim H, Kupelian V, Tikkinen KA, et al. Nocturia: current levels of evidence and recommendations from the international consultation on male lower urinary tract symptoms. Urology. 2015;85(6):1291\u20139.","journal-title":"Urology"},{"issue":"9","key":"845_CR5","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1464-410X.2004.05175.x","volume":"94","author":"A Semercioz","year":"2004","unstructured":"Semercioz A, Onur R, Ayar A, Orhan I. The inhibitory role of melatonin on isolated guinea-pig urinary bladder: an endogenous hormone effect. BJU Int. 2004;94(9):1373\u20136.","journal-title":"BJU Int"},{"issue":"5","key":"845_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/147323000703500513","volume":"35","author":"K Sugaya","year":"2007","unstructured":"Sugaya K, Nishijima S, Miyazato M, Kadekawa K, Ogawa Y. Effects of melatonin and rilmazafone on nocturia in the elderly. J Int Med Res. 2007;35(5):685\u201391.","journal-title":"J Int Med Res"},{"issue":"3","key":"845_CR7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/01.ju.0000110442.47593.ea","volume":"171","author":"MJ Drake","year":"2004","unstructured":"Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004;171(3):1199\u2013202.","journal-title":"J Urol"},{"issue":"1\u20132","key":"845_CR8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2015.03.040","volume":"353","author":"A Damasceno","year":"2015","unstructured":"Damasceno A, Moraes AS, Farias A, Damasceno BP, dos Santos LM, Cendes F. Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study. J Neurol Sci. 2015;353(1\u20132):166\u20138.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"845_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2011.11.003","volume":"314","author":"L Melamud","year":"2012","unstructured":"Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci. 2012;314(1\u20132):37\u201340.","journal-title":"J Neurol Sci"},{"key":"845_CR10","doi-asserted-by":"crossref","unstructured":"Cardinali DP, Hardeland R. Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies. Neuroendocrinology. 2016. [Epub ahead of print].","DOI":"10.1159\/000446543"},{"issue":"6","key":"845_CR11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2174\/1871527313666140806160400","volume":"13","author":"BM Escribano","year":"2014","unstructured":"Escribano BM, Colin-Gonzalez AL, Santamaria A, Tunez I. The role of melatonin in multiple sclerosis, Huntington\u2019s disease and cerebral ischemia. CNS Neurol Disord Drug Targets. 2014;13(6):1096\u2013119.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"845_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.msard.2014.12.001","volume":"4","author":"G Anderson","year":"2015","unstructured":"Anderson G, Rodriguez M. Multiple sclerosis: the role of melatonin and N-acetylserotonin. Mult Scler Relat Disord. 2015;4(2):112\u201323.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"845_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"845_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1191\/1352458503ms971oa","volume":"9","author":"RA Marrie","year":"2003","unstructured":"Marrie RA, Miller DM, Chelune GJ, Cohen JA. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult Scler. 2003;9(6):621\u20136.","journal-title":"Mult Scler"},{"issue":"2 Pt 1","key":"845_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1212\/WNL.39.2.291","volume":"39","author":"JF Kurtzke","year":"1989","unstructured":"Kurtzke JF. The disability status scale for multiple sclerosis: apologia pro DSS sua. Neurology. 1989;39(2 Pt 1):291\u2013302.","journal-title":"Neurology"},{"issue":"3 Pt 1","key":"845_CR16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5347(05)00348-4","volume":"175","author":"P Abrams","year":"2006","unstructured":"Abrams P, Avery K, Gardener N, Donovan J. The international consultation on incontinence modular questionnaire: www.iciq.net . J Urol. 2006;175(3 Pt 1):1063\u20136. discussion 6.","journal-title":"J Urol"},{"issue":"3","key":"845_CR17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.urology.2003.10.019","volume":"63","author":"L Abraham","year":"2004","unstructured":"Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004;63(3):481\u20136.","journal-title":"Urology"},{"issue":"2","key":"845_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds 3rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213.","journal-title":"Psychiatry Res"},{"issue":"4","key":"845_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1464-410x.2000.00525.x","volume":"85","author":"H Sells","year":"2000","unstructured":"Sells H, Donovan J, Ewings P, MacDonagh RP. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int. 2000;85(4):440\u20135.","journal-title":"BJU Int"},{"issue":"4","key":"845_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1355617706060723","volume":"12","author":"RH Benedict","year":"2006","unstructured":"Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006;12(4):549\u201358.","journal-title":"J Int Neuropsychol Soc"},{"key":"845_CR21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1025027231938","volume":"33","author":"H Niederhofer","year":"2003","unstructured":"Niederhofer H, Staffen W, Mair A, Pittschieler K. Brief report: Melatonin facilitates sleep in individuals with mental retardation and insomnia. J Autism Dev Disord. 2003;33:469\u201372.","journal-title":"J Autism Dev Disord"},{"key":"845_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1745-6215-10-27","volume":"10","author":"EJ Mills","year":"2009","unstructured":"Mills EJ, Chan A, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis, and presentation of crossover trials. Trials. 2009;10:27.","journal-title":"Trials"},{"key":"845_CR23","doi-asserted-by":"crossref","DOI":"10.4324\/9780203009277","volume-title":"Design and analysis of cross-over trials","author":"B Jones","year":"1989","unstructured":"Jones B, Kenward MG. Design and analysis of cross-over trials. New York: Chapman and Hall; 1989."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T22:53:17Z","timestamp":1658875997000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0845-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2017,3,27]]},"article-number":"63"}}